Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Sufentanil vs Ketamine for Severe Acute Trauma-Related Pain in Children
2025-521075-31-00Phase 2Authorised
- Sponsor
- Fondation Lenval
- Start
- Sep 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Injury-Related Pain comparing Intranasal Sufenta with Intranasal ketamine (2 arms). Planned start Sep 2025; status: authorised.
02
Drugs
sufentanilketamine
03
Conditions
Injury-Related Pain
Beyond the preview
Go deeper on 2025-521075-31-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-521075-31-00.